Edition:
United Kingdom

Healios KK (4593.T)

4593.T on Tokyo Stock Exchange

1,263JPY
6:07am BST
Change (% chg)

¥-41 (-3.14%)
Prev Close
¥1,304
Open
¥1,265
Day's High
¥1,274
Day's Low
¥1,257
Volume
53,400
Avg. Vol
197,585
52-wk High
¥2,180
52-wk Low
¥1,212

Latest Key Developments (Source: Significant Developments)

Athersys And Healios Extend By One Month The Period To Complete Collaboration Expansion Agreements
Tuesday, 1 May 2018 

May 1 (Reuters) - Healios KK <4593.T>::ATHERSYS AND HEALIOS EXTEND BY ONE MONTH THE PERIOD TO COMPLETE COLLABORATION EXPANSION AGREEMENTS.ATHERSYS INC - CO, HEALIOS K.K. AGREED TO EXTEND PERIOD FROM APRIL 30, 2018 TO MAY 31, 2018.  Full Article

Athersys and Healios announce binding letter of intent to expand multistem collaboration
Tuesday, 13 Mar 2018 

March 13 (Reuters) - Athersys Inc ::ATHERSYS AND HEALIOS ANNOUNCE BINDING LETTER OF INTENT TO EXPAND MULTISTEM® COLLABORATION.CO, HEALIOS K.K. ANNOUNCED INTENT TO SIGNIFICANTLY EXPAND THEIR EXISTING DEVELOPMENT AND COMMERCIALIZATION COLLABORATION​.WOULD RECEIVE COMMITTED PAYMENTS OF $35 MILLION, AS WELL AS ADDITIONAL PAYMENTS, INCLUDING MILESTONES AND ROYALTIES..ATHERSYS- ‍AS PART OF THIS EXPANSION, HEALIOS IS MAKING AN APPROXIMATE $21 MILLION EQUITY INVESTMENT AT $1.76 PER SHARE, WILL DEPOSIT $10 MILLION INTO ESCROW​.‍HEALIOS WILL OBTAIN EXCLUSIVE OPTION TO LICENSE TO COMMERCIALIZE MULTISTEM PRODUCTS FOR ISCHEMIC STROKE, ARDS AND TRAUMA IN CHINA​.DR. HARDY KAGIMOTO, CEO OF HEALIOS, WOULD BE NOMINATED FOR ELECTION TO ATHERSYS BOARD AT NEXT ANNUAL MEETING IN JUNE 2018.WILL PAY AN ADDITIONAL $25 MILLION IN LICENSE/OPTION FEES, IN INSTALLMENTS.  Full Article

Healios to set up U.S.-based unit Healios N.A.
Tuesday, 13 Feb 2018 

Feb 13 (Reuters) - Healios KK <4593.T>:Says it will set up a wholly owned unit Healios N.A. Inc, which will be engaged in development of medical supplies in March .Says the unit will be capitalized at $150,000.  Full Article

Healios says exercise of options
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Healios KK <4593.T>:Says 8,000 units of its 10th series options were exercised to 800,000 shares of its common stock from Nov. 1 to Nov. 20.Says 3,000 units of its 10th series options were exercised to 300,000 shares of its common stock on Nov. 2, at the price of 1,314 yen per share.Says 5,000 units of its 10th series options were exercised to 500,000 shares of its common stock on Nov. 20, at the price of 1,304 yen per share.  Full Article

Healios says First Patient is enrolled in clinical trial of adult stem cell regenerative medicine HLCM051 in patients with ischemic stroke in Japan
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Healios KK <4593.T>:Says it announces that the first patient has been enrolled and treated in a clinical trial of adult stem cell regenerative medicine HLCM051 in patients with acute ischemic stroke in Japan, named TREASURE study .  Full Article

Healios announces exercise of options
Monday, 30 Oct 2017 

Oct 30(Reuters) - Healios KK <4593.T>:Says 12,000 units of its tenth series options were exercised to 1.2 million shares of its common stock from Oct. 2 to Oct. 30.  Full Article